首页 > 市场调查报告书 > 製药

眼科药物

市场调查报告书

商品编码

1391891

眼科流感市场：依疾病类型、依给药途径、依药物类别、依配销通路、按地区

Eye Flu Market, By Disease Type, By Route of Administration, By Drug Class, By Distribution Channel, By Geography

出版日期: 2023年10月31日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

全球眼流感市场规模预计将从 2023 年的 45.4 亿美元增至 2030 年的 77.7 亿美元，预测期内CAGR为 8.0%。

报告范围		报告详情
基准年	2022年	2023年市场规模	45.4亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期CAGR	8.00%	2030年市场规模预测	77.7亿美元

图 1. 2023 年眼流感全球市场占有率（按地区划分）

眼流感，也称为结膜炎，是一种常见的眼部感染疾病，影响全世界数百万人。结膜炎的特征是结膜发炎，结膜是覆盖眼睛白色部分并排列在眼睑内侧的透明薄层。这种情况可能由多种因素引起，包括病毒和细菌感染、过敏和刺激物。

全球眼流感市场竞争激烈，多家主要企业占据产业主导。市场的主要参与者包括诺华公司、艾尔建、Bausch Health、参天製药、强生公司和 Alembic 製药公司。这些公司提供多种眼部流感产品和治疗方法，包括眼药水、药膏和内服药物。

市场动态：

全球眼流感市场的成长是由多种因素推动的，例如眼部感染疾病盛行率的增加、对眼睛健康意识的提高以及医疗技术的进步。老年人口的增加以及过敏和刺激物发生率的增加也促进了市场的成长。

然而，也存在阻碍全球眼流感市场成长的因素。其中包括高昂的治疗费用、发展中地区医疗机构的使用机会有限以及替代治疗方法的可用性。他们也面临严格的监管要求以及与某些药物相关的副作用风险等挑战。

儘管有这些挑战，全球眼流感市场仍存在许多成长机会。新兴经济体对有效和安全治疗方法的需求开拓、创新产品的开发以及医疗基础设施的扩建预计将在不久的将来推动市场成长。

本研究的主要特点

本报告对全球眼流感市场进行了详细分析，包括以2022年为基准年的预测期（2023-2030年）的市场规模和CAGR。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
该报告的见解将使公司行销人员和负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
全球眼流感市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球眼流感市场的各种策略矩阵，将促进相关人员的决策。

介绍
北美洲
美国
加拿大
欧洲
德国
英国
西班牙
法国
义大利
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
澳洲
韩国
东南亚国协
其他亚太地区
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中东
海湾合作委员会国家
以色列
其他中东地区
非洲
南非
北非
中部非洲

第10章竞争形势

Novartis AG
Allergan
Bausch Health
Santen Pharmaceutical
Johnson & Johnson
Alembic Pharmaceuticals
Akorn Pharmaceuticals
Alcon
Pfizer
Valeant Pharmaceuticals
Merck & Co.
Similasan Corporation
Sun Pharmaceutical Industries
Prestige Consumer Healthcare
Lupin Pharmaceuticals
Alembic Pharmaceuticals
Aurolab
Intas Pharmaceuticals
Sun Pharma
Cipla

第11章章节

调查方法
关于出版商

简介目录

Product Code: CMI6211

Global eye flu (conjunctivitis) market size is expected to reach US$ 7.77 billion by 2030, from US$ 4.54 billion in 2023, exhibiting a CAGR of 8.0% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 4.54 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8.00%	2030 Value Projection:	US$ 7.77 Bn

Figure 1. Global Eye Flu (Conjunctivitis) Market Share (%), By Region, 2023

Eye flu, also known as conjunctivitis, is a common eye infection that affects millions of people worldwide. It is characterized by inflammation of the conjunctiva, the thin, transparent layer that covers the white part of the eye and lines the inner surface of the eyelids. This condition can be caused by various factors including viral or bacterial infections, allergies, or irritants.

Global eye flu (conjunctivitis) market is highly competitive, with several key players dominating the industry. Novartis AG, Allergan, Bausch Health, Santen Pharmaceutical, Johnson & Johnson, and Alembic Pharmaceuticals are some of the leading companies in this market. These companies offer a wide range of products and treatments for eye flu including eye drops, ointments, and oral medications.

Market Dynamics:

Global eye flu (conjunctivitis) market growth is driven by several factors including the increasing prevalence of eye infections, growing awareness about eye health, and advancements in medical technology. Rising geriatric population and increasing incidence of allergies and irritants also contributes to the market growth.

However, there are certain restraints that may hinder growth of the global eye flu (conjunctivitis) market. These include the high cost of treatment, limited access to healthcare facilities in developing regions, and the availability of alternative treatments. The market faces challenges such as stringent regulatory requirements and the risk of adverse effects associated with certain medications.

Despite these challenges, the global eye flu (conjunctivitis) market presents numerous opportunities for growth. Increasing demand for effective and safe treatments, the development of innovative products, and the expansion of healthcare infrastructure in emerging economies are expected to drive the market growth in the near future.

Key Features of the Study:

This report provides in-depth analysis of the global eye flu (conjunctivitis) market, including market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key companies covered as a part of this study include Novartis AG, Allergan, Bausch Health, Santen Pharmaceutical, Johnson & Johnson, Alembic Pharmaceuticals, Akorn Pharmaceuticals, Alcon, Pfizer, Valeant Pharmaceuticals, Merck & Co., Similasan Corporation, Sun Pharmaceutical Industries, Prestige Consumer Healthcare, Lupin Pharmaceuticals, Alembic Pharmaceuticals, Aurolab, Intas Pharmaceuticals, Sun Pharma, and Cipla
Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global eye flu (conjunctivitis) market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye flu (conjunctivitis) market

Detailed Segmentation:

By Disease Type
- Viral Conjunctivitis
- Bacterial Conjunctivitis
- Allergic Conjunctivitis
- Chemical Conjunctivitis
- Others
By Route of Administration
- Topical
- Oral
- Intravenous
By Drug Class
- Antibiotics
- Anti-allergy
- Anti-inflammatories
- Combination
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Novartis AG
- Allergan
- Bausch Health
- Santen Pharmaceutical
- Johnson & Johnson
- Alembic Pharmaceuticals
- Akorn Pharmaceuticals
- Alcon
- Pfizer
- Valeant Pharmaceuticals
- Merck & Co.
- Similasan Corporation
- Sun Pharmaceutical Industries
- Prestige Consumer Healthcare
- Lupin Pharmaceuticals
- Alembic Pharmaceuticals
- Aurolab
- Intas Pharmaceuticals
- Sun Pharma
- Cipla

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Disease Type
- Market Snippet, By Route of Administration
- Market Snippet, By Drug Class
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Eye Flu (Conjunctivitis) Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Eye Flu (Conjunctivitis) Market, By Disease Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Viral Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Bacterial Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Allergic Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Chemical Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Eye Flu (Conjunctivitis) Market, By Route of Administration, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Eye Flu (Conjunctivitis) Market, By Drug Class, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Anti-allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Anti-inflammatories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Combination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Eye Flu (Conjunctivitis) Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Eye Flu (Conjunctivitis) Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Allergan
Bausch Health
Santen Pharmaceutical
Johnson & Johnson
Alembic Pharmaceuticals
Akorn Pharmaceuticals
Alcon
Pfizer
Valeant Pharmaceuticals
Merck & Co.
Similasan Corporation
Sun Pharmaceutical Industries
Prestige Consumer Healthcare
Lupin Pharmaceuticals
Alembic Pharmaceuticals
Aurolab
Intas Pharmaceuticals
Sun Pharma
Cipla
Analyst Views